跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OLMATRIO 40 MG/10 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
OLMATRIO 40 MG/10 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
OLMATRIO 40 MG/10 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Merck Healthcare Kgaa
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Oct 1, 2020
Approval ID
90176c102169997f
Company
Merck Healthcare Kgaa
Type
Standard
Approval Details
Approval Id
90176c102169997f
Drug Cima Aemps Name
OLMATRIO 40 MG/10 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
85445
Holder Company Name
Merck Healthcare Kgaa
Marketing Company Name
Merck Healthcare Kgaa
Holder Company Detail Path
/organization/merck-healthcare-kgaa
Marketing Company Detail Path
/organization/merck-healthcare-kgaa
Authorization Date
2020-10-01
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
40 mg/10 mg/12,5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Merck Healthcare Kgaa
Company Detail Path
/organization/merck-healthcare-kgaa
Company Information
Pharmaceutical Company Name
Merck Healthcare KGaA
Country Name
Germany
City Name
darmstadt,hessen,country_de
Address
Frankfurter Str. 250
Active Ingredients
OLMESARTAN MEDOXOMILO
40 mg
AMLODIPINO BESILATO
13,9 mg
HIDROCLOROTIAZIDA
12,5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Oct 1, 2020
Approval ID
90176c102169997f
Type
Standard
Back to CIMA-AEMPS Approvals